Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ETNB

89bio (ETNB)

89bio Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ETNB
日付受信時刻ニュースソース見出しコード企業名
2024/06/0105 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2024/05/1005 : 45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETNB89bio Inc
2024/05/1005 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2024/03/0207 : 06Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:ETNB89bio Inc
2024/03/0207 : 03Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ETNB89bio Inc
2024/03/0106 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2024/02/2410 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/2410 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/1501 : 32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ETNB89bio Inc
2024/02/1411 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/1411 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/0610 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/0610 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/0610 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/02/0610 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/01/0908 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2024/01/0908 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2023/12/0906 : 43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/12/0820 : 08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ETNB89bio Inc
2023/12/0706 : 40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ETNB89bio Inc
2023/12/0706 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/12/0421 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/11/2722 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/11/1506 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/11/1005 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETNB89bio Inc
2023/11/0910 : 41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
2023/09/2122 : 07Dow Jones News89bio Gets FDA Breakthrough Designation for Pegozafermin in NASHNASDAQ:ETNB89bio Inc
2023/09/1305 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2023/09/1305 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
2023/08/2206 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
 Showing the most relevant articles for your search:NASDAQ:ETNB

最近閲覧した銘柄